UCB and argenx have carried the Bel20 since October, and on Friday 0.08 percent was enough for record number 34
Brussels stayed calm while chip stocks in Europe and on Wall Street came under pressure from the turmoil at Nvidia and rising US interest rates.
The Bel20 closed 0.08 percent higher on Friday at 6,119.66 points, its 34th closing record of the year, Belga reports in a market wrap published by La Libre. Twelve of the twenty stocks rose, led by KBC (+0.95 percent) and Montea (+0.85 percent). Umicore lost 2.7 percent with no clear trigger, Beursduivel writes. Lotus Bakeries fell 1.4 percent after KBC Securities cut its rating from buy to accumulate because of the high valuation, although the bank raised its price target to 14,500 euros. Outside the main index, Agfa-Gevaert (-5 percent) and bpost (-4.2 percent) stood out, while Retail Estates gained 2.4 percent after better results and a higher forecast.
Since early October the Bel20 has climbed 9.1 percent, with five closing records in November alone, and more than 20 percent since January, La Libre calculates. The paper attributes much of the rally to two biotech companies: UCB, up about 39 percent since 22 October after strong quarterly figures and higher targets, and argenx, which gained 13 percent over the same period on good sales of its drug Vyvgart.
Elsewhere the picture was mixed. Europe's Stoxx 600 closed almost flat but gained 2.4 percent over the week. Chip stocks such as ASML, Besi and Infineon lost 2.5 to 4.3 percent on concerns about Nvidia, Beursduivel reports. On Wall Street the Nasdaq fell 0.9 percent and the S&P 500 0.4 percent, while the Dow Jones closed 0.1 percent higher, according to AFP. After high US producer prices, 6.5 percent above their level a year earlier, investors expect the Fed to raise rates on 9 December, Beursduivel says. The US ten-year yield stood at around 5.13 percent.